DOH sees shortage of COVID drug Tocilizumab till December

DOH sees shortage of COVID drug Tocilizumab till December

Bibliographic Details
Published in:Philippine Daily Inquirer Vol. 36, no. 269 (05 Sep. 2021), A2
Main Author: Salaverria, Leila B.
Resource Type: Article
Language:English
Published: 2021
Subjects:
Tocilizumab (Drug)
COVID-19 treatment
Combination drug therapy
Rheumatoid arthritis treatment
Philippines. Department of Health
LEADER 00687cab a22002414a 4500
001 IPN-00000769681
003 IPN
005 20210906152126.0
008 210906s2021 xx d | ||r |||||eng||
041 # # |a eng 
100 1 # |a Salaverria, Leila B. 
245 1 0 |a DOH sees shortage of COVID drug Tocilizumab till December 
264 # 1 |c 2021 
300 # # |b photograph 
650 1 0 |a Tocilizumab (Drug) 
650 2 0 |a COVID-19 treatment 
650 2 0 |a Combination drug therapy 
650 2 0 |a Rheumatoid arthritis treatment 
650 2 0 |a Philippines. Department of Health 
773 0 # |t Philippine Daily Inquirer  |g Vol. 36, no. 269 (05 Sep. 2021), A2 
852 # # |a UPD  |b DMLP 
942 # # |a Article 
950 # # |a FI